Which hedge funds own GOSS? GOSSAMER BIO INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in GOSS (GOSSAMER BIO INC) in their Q2 2026 13F filings, worth $9.5m in total. The largest holder by portfolio weight is D. E. Shaw & Co at 0.0% of its book. 2 managers opened a new position this quarter: Bronte Capital, Marshall Wace.
6tracked managers holding
2opened this quarter
0exited this quarter
Which hedge funds hold GOSS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co | Q2 2026 | 0.0% | $6.7m | 40,959,285 | 10418% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.9m | 11,629,896 | 855% | added |
| Bronte Capital | Q2 2026 | 0.0% | $11.2k | 67,754 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $78.9k | 479,581 | 316% | added |
| Marshall Wace | Q2 2026 | 0.0% | $338.4k | 2,114,988 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $395.5k | 2,402,633 | 1182% | added |
How has hedge fund ownership of GOSS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $9.5m |
| Q1 2026 | 4 | $627.4k |
| Q4 2025 | 2 | $2.2m |
| Q3 2025 | 3 | $9.3m |
| Q2 2025 | 3 | $4.0m |
| Q1 2025 | 3 | $2.6m |
| Q4 2024 | 3 | $2.3m |
| Q3 2024 | 3 | $2.5m |
| Q2 2024 | 3 | $2.6m |
| Q1 2024 | 4 | $8.3m |
| Q4 2023 | 3 | $6.5m |
| Q3 2023 | 2 | $5.1m |
| Q2 2023 | 2 | $97.7k |
| Q1 2023 | 2 | $126.6k |
| Q3 2022 | 4 | $22.9m |
| Q2 2022 | 3 | $18.1m |
Counts every tracked manager that disclosed GOSS in that quarter's filing, including managers that have since stopped filing.